158 related articles for article (PubMed ID: 6273028)
1. A possible direct effect of 24,25-dihydroxycholecalciferol on the parathyroid gland in patients with chronic renal failure.
Christiansen C; Rødbro P; Naestoft J; Christensen MS
Clin Endocrinol (Oxf); 1981 Sep; 15(3):237-42. PubMed ID: 6273028
[TBL] [Abstract][Full Text] [Related]
2. Chronic renal failure and vitamin D metabolites: a status report.
Christiansen C
J Steroid Biochem; 1983 Jul; 19(1B):517-23. PubMed ID: 6310241
[TBL] [Abstract][Full Text] [Related]
3. Decreased renal function in association with administration of 1,25-dihydroxyvitamin D3 to patients with stable, advanced renal failure.
Christiansen C; Røodbro P; Christensen MS; Naestoft J; Hartnack B; Transbøol I
Contrib Nephrol; 1980; 18():139-46. PubMed ID: 6243527
[TBL] [Abstract][Full Text] [Related]
4. Is 1,25-dihydroxy-cholecalciferol harmful to renal function in patients with chronic renal failure?
Christiansen C; Rødbro P; Christensen MS; Hartnack B
Clin Endocrinol (Oxf); 1981 Sep; 15(3):229-36. PubMed ID: 6273027
[TBL] [Abstract][Full Text] [Related]
5. Deterioration of renal function during treatment of chronic renal failure with 1,25-dihydroxycholecalciferol.
Christiansen C; Rødbro P; Christensen MS; Hartnack B; Transbøl I
Lancet; 1978 Sep; 2(8092 Pt 1):700-3. PubMed ID: 80633
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D3 metabolites in chronic renal failure and after renal transplantation.
Lucas PA; Woodhead JS; Brown RC
Nephrol Dial Transplant; 1988; 3(1):70-6. PubMed ID: 3132643
[TBL] [Abstract][Full Text] [Related]
7. 1,25 dihydroxycholecalciferol effects in chronic dialysis. A double-blind controlled study.
Berl T; Berns AS; Hufer WE; Hammill K; Alfrey AC; Arnaud CD; Schrier RW
Ann Intern Med; 1978 Jun; 88(6):774-80. PubMed ID: 208439
[TBL] [Abstract][Full Text] [Related]
8. Aminoaciduria in chronic renal failure--its relationship to vitamin D and parathyroid status.
Phillips ME; Havard J; Otterud B
Am J Clin Nutr; 1980 Jul; 33(7):1541-5. PubMed ID: 6893104
[TBL] [Abstract][Full Text] [Related]
9. Serum 1,25-dihydroxycholecalciferol in anephric, haemodialyzed and kidney-transplanted patients. Effect of vitamin D3 supplement.
Lund B; Clausen E; Friedberg M; Lund B; Moszkowicz M; Nielsen SP; Sørensen OH
Nephron; 1980; 25(1):30-3. PubMed ID: 6243405
[TBL] [Abstract][Full Text] [Related]
10. Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combination.
Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Eade Y; Johnson JR; George CR; Collett P
Miner Electrolyte Metab; 1985; 11(6):358-68. PubMed ID: 3877862
[TBL] [Abstract][Full Text] [Related]
11. Effect of 24,25-dihydroxyvitamin D3 on 1,25-dihydroxyvitamin D3 metabolism in calcium-deficient rats.
Matsumoto T; Ikeda K; Yamato H; Morita K; Ezawa I; Fukushima M; Nishii Y; Ogata E
Biochem J; 1988 Mar; 250(3):671-7. PubMed ID: 2839142
[TBL] [Abstract][Full Text] [Related]
12. Controlled trial of the effects of 1,25-dihydroxycholecalciferol in patients treated with regular dialysis.
Berl T; Berns AS; Huffer WE; Alfrey AC; Arnaud CD; Schrier RR
Contrib Nephrol; 1980; 18():72-81. PubMed ID: 6243528
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of a lack of change in serum 1 alpha,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism.
Lambert PW; Hollis BW; Bell NH; Epstein S
J Clin Invest; 1980 Oct; 66(4):782-91. PubMed ID: 7419719
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D metabolite concentrations in vitamin D deficiency. Are calcitriol levels normal.
Chesney RW; Zimmerman J; Hamstra A; DeLuca HF; Mazees RB
Am J Dis Child; 1981 Nov; 135(11):1025-8. PubMed ID: 6271009
[TBL] [Abstract][Full Text] [Related]
15. Long-term treatment of postmenopausal osteoporosis with active vitamin D3, 1-alpha-hydroxycholecalciferol (1 alpha-OHD3) and 1, 24 Dihydroxycholecalciferol (1, 24(OH)2D3).
Shiraki M; Orimo H; Ito H; Akiguchi I; Nakao J; Takahashi R; Ishizuka S
Endocrinol Jpn; 1985 Apr; 32(2):305-15. PubMed ID: 2995014
[TBL] [Abstract][Full Text] [Related]
16. The effects of calciferol and its metabolites on patients with chronic renal failure. II. Calcitriol, 1 alpha-hydroxyvitamin D3, and 24,25-dihydroxyvitamin D3.
Voigts AL; Felsenfeld AJ; Llach F
Arch Intern Med; 1983 Jun; 143(6):1205-11. PubMed ID: 6344827
[TBL] [Abstract][Full Text] [Related]
17. 24,25-dihydroxy vitamin D3 treatment inhibits parathyroid-stimulated adenylate cyclase in iliac crest biopsies from uremic patients.
Mortensen BM; Aarseth HP; Ganss R; Haug E; Gautvik KM; Gordeladze JO
Bone; 1993; 14(2):125-31. PubMed ID: 8334029
[TBL] [Abstract][Full Text] [Related]
18. [Parathormone and vitamin d3-metabolites in healthy children and children with chronic renal failure before and after kidney transplantation].
Pistor K; Reinhardt D; Grosse-Hohmann E; Keck E
Monatsschr Kinderheilkd; 1982 Sep; 130(9):714-20. PubMed ID: 6755227
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D metabolism in pregnant rabbits: differences between the maternal and fetal response to administration of large amounts of vitamin D3.
Kubota M; Ohno J; Shiina Y; Suda T
Endocrinology; 1982 Jun; 110(6):1950-6. PubMed ID: 6280980
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D3 metabolites in hypercalcaemic adults after kidney transplantation.
Lucas PA; Brown RC; Bloodworth L; Woodhead JS
Proc Eur Dial Transplant Assoc; 1983; 20():213-9. PubMed ID: 6318219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
